Vidant, GT Medical Technologies Announce First Patient Treated in Registry Trial of Gammatile Therapy for Brain Tumors | Eastern North Carolina Now

Press Release:

    Greenville, N.C.     Vidant Health and GT Medical Technologies, Inc., a company dedicated to improving the lives of patients with brain tumors, announced the first patient has been enrolled into its registry trial of GammaTile®, a FDA-cleared, Surgically Targeted Radiation Therapy (STaRT) for newly diagnosed malignant and recurrent brain tumors. The study will evaluate the safety and effectiveness of GammaTile Therapy in a real-world setting in up to 50 brain tumor centers across the United States.

    "GammaTile Therapy was created with the goal of elevating the standard of care, and this registry will help demonstrate how it is making a measurable impact on patients diagnosed with brain tumors," said Matt Likens, President and CEO of GT Medical Technologies. "We have been encouraged by previous studies showing that GammaTile Therapy delays recurrence and may extend survival, which led to FDA clearance. This registry will shed further light on the real-world benefits of STaRT for people with brain tumors."

    The multicenter observational study will enroll 600 patients with brain tumors of any pathology who have received treatment with GammaTile Therapy. Data will be collected before and after surgery and implantation of GammaTiles and at 1, 3, 6, 9, 12, 18 and 24 months, then every 6 months through 5 years. Primary and secondary endpoints will include local tumor control, overall survival, quality of life, physical function, and safety. This will be the first observational registry study of resection plus GammaTile. Data from the study will be used to benchmark clinical outcomes for GammaTile Therapy and allow for comparisons to existing standard-of-care treatments for patients with brain tumors.

    Over 700,000 Americans are living with a brain tumor today. Despite the efforts of the most skilled brain tumor specialists in the world, outcomes for patients with brain tumors have improved little over the past 30 years. GammaTile is the latest FDA-cleared treatment for newly diagnosed malignant and recurrent brain tumors, and recently announced data show promising clinical outcomes for patients diagnosed with high grade gliomas, brain metastases, and aggressive meningiomas.

    "As a neurosurgeon, I am always looking for treatments that help give my patients more time and a better quality of life, and from what I have seen in my patients to date, GammaTile Therapy offers both," said Dr. Stuart Lee, Chief of Neurosurgery at Vidant Medical Center in Greenville, North Carolina. "It is an honor to have treated and enrolled the first patient in this registry. My hope is that the insights gleaned from this study will give us information to continue improving the standard of care for patients with brain tumors."

    In addition to the registry trial, two additional studies evaluating GammaTile Therapy in patients with brain metastases were announced at the 2020 Society of Neuro-Oncology Virtual Meeting on Brain Metastases in August. Those studies, which are led by The University of Texas MD Anderson Cancer Center and Memorial Sloan Kettering Cancer Center, are expected to begin enrollment in Q4 2020.


  • Contact: Brian Wudkwych
  •     brian.wudkwych@vidanthealth.com

Go Back


Leave a Guest Comment

Your Name or Alias
Your Email Address ( your email address will not be published)
Enter Your Comment ( no code or urls allowed, text only please )




Dr. Christina Bowen Honored on National Rural Health Day Vidant Health, Body & Soul, Health and Fitness That Is Stupid/Crazy!


HbAD0

Latest Health and Fitness

The North Carolina Department of Health and Human Services is launching a Community Partner Engagement Plan to ensure the voices of North Carolina communities and families continue to be at the center of the department’s work.
The North Carolina Department of Health and Human Services will host a live Spanish-language Cafecito and tele-town hall on Tuesday, Feb. 27, from 6 to 7 p.m., to discuss how to support and improve heart health as well as prevent and manage heart disease.
Part of ongoing effort to raise awareness and combat rising congenital syphilis cases
Recognition affirms ECU Health’s commitment to providing highly-reliable, human-centered care
The North Carolina Department of Health and Human Services is launching a new Statewide Peer Warmline on Feb. 20, 2024. The new Peer Warmline will work in tandem with the North Carolina 988 Suicide and Crisis Lifeline by giving callers the option to speak with a Peer Support Specialist.
A subsidiary of one of the largest health insurance agencies in the U.S. was hit by a cyberattack earlier this week from what it believes is a foreign “nation-state” actor, crippling many pharmacies’ ability to process prescriptions across the country.
The John Locke Foundation is supporting a New Bern eye surgeon's legal fight against North Carolina's certificate-of-need restrictions on healthcare providers.
The North Carolina Department of Health and Human Services today released the following statement on the Trails Carolina investigation:
The North Carolina Department of Health and Human Services today released a draft of its 2024-25 Olmstead Plan designed to assist people with disabilities to reside in and experience the full benefit of inclusive communities.

HbAD1

The North Carolina Department of Health and Human Services will host a live fireside chat and tele-town hall on Tues., Feb. 20, from 6 to 7 p.m., to discuss how to support and improve heart health as well as prevent and manage heart disease.
The North Carolina Department of Health and Human Services is investing $5.5 million into the FIT Wellness program, part of the North Carolina Formerly Incarcerated Transition Program in the UNC School of Medicine, to improve reentry services for the justice-involved population.
As of Feb. 1, 2024, 346,408 newly eligible North Carolinians are enrolled in Medicaid and now have access to comprehensive health care, according to the North Carolina Department of Health and Human Services’ Medicaid Expansion Enrollment Dashboard.
Controversy surrounds a healthcare provider’s decision to block parents from having access to their children’s prescription records.
Members of the North Carolina Rural Health Association (NCRHA) visited Washington, D.C., on Feb. 14, 2024, to meet with elected officials and advocate for policies to improve access to care in rural areas.
The North Carolina Department of Health and Human Services today released the request for proposal to hire the organization that will help manage the Children and Families Specialty Plan.
As part of its commitment to improve the health and well-being of North Carolina children and families, the North Carolina Department of Health and Human Services today announced the launch of its Child Behavioral Health dashboard.
February is National Children's Dental Health Month, and the North Carolina Department of Health and Human Services is emphasizing the importance of children's dental hygiene to overall health and well-being.

HbAD2

 
Back to Top